Coherus Bolsters Top Team As It Prepares For Launches

Company Lines Up Ranibizumab, Adalimumab And On-Body Pegfilgrastim Biosimilars

Mar 17 2022

• By David Wallace

Coherus has recently announced a trio of appointments • Source: Pavel Kapish / Alamy Stock Photo

More from Leadership

More from Generics Bulletin